Nyala specialized hospital
Darfur, 00000, Sudan
NCT Number: NCT06156787
Background: Bladder cancer (BC) exhibits extreme heterogeneity regarding clinical outcome, etiology, histology, and geographic distribution. Recent clinical observations point to alterations in the BC pattern in the Sudan, possibly as a result of lifestyle changes brought on by the enormous migration from rural to urban locations. This study aimed to identify the pattern of bladder cancer in Darfur.
Patients and Methods: A cross sectional, hospital-based study, it was conducted inNyala specialized hospital, during the period from (2020 to 2022), included one hundred and five patients with bladder mass matching the inclusion criteria were studied over the diversity of demographic data , clinical finding, pathological type and possible risk factors .
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Darfur, 00000, Sudan
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: The research is a cross-sectional, hospital-based study conducted at Nyala Specialized Hospital in Darfur. The study spans a period from 2020 to 2022.
This research study investigates the patterns of urinary bladder cancer (BC) in Darfur, Sudan, with a focus on understanding the clinical outcomes, etiology, histology, and demographic distribution of the disease.
National Center for Gastroentestinal and Liver Disease
Other
Patterns of Urinary Bladder Cancer in Darfur, Sudan 2020 - 2022
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07259798
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Cairo, Abbasia, Egypt
View Trial DetailsNCT06582849
Adnexal Diseases, Anal Cancer
St Louis, Missouri, United States
View Trial DetailsNCT03433924
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Beijing, China
View Trial DetailsNCT03998579
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Stockholm, Sweden
View Trial Details